Institutional Ownership
Briacell Therapeutics Corp
CUSIP 107930125*W EXP 01/15/203Q1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
15
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Citadel Advisors LLC | 1.05M | $1.05M |
| 2 | Armistice Capital, LLC | 536.6K | $552.8K |
| 3 | Sabby Management, LLC | 380.7K | $392.1K |
| 4 | Cable Car Capital, LP | 321.9K | $331.6K |
| 5 | Empery Asset Management, LP | 300.0K | $309.0K |
| 6 | Heights Capital Management, Inc | 300.0K | $300.0K |
| 7 | Myda Advisors LLC | 200.0K | $206.0K |
| 8 | Hudson Bay Capital Management LP | 125.4K | $125.4K |
| 9 | Warberg Asset Management LLC | 115.0K | $118.5K |
| 10 | Clear Street Group Inc. | 104.2K | $107.3K |